| 94.91 0.9 (0.96%) | 08-18 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 120.89 | 1-year : | 128.47 |
| Resists | First : | 103.51 | Second : | 110 |
| Pivot price | 98.75  |
|||
| Supports | First : | 93.01 | Second : | 77.38 |
| MAs | MA(5) : | 95.15 |
MA(20) : | 100.99 |
| MA(100) : | 92.57 |
MA(250) : | 82.35 |
|
| MACD | MACD : | -2.5 |
Signal : | -1.6 |
| %K %D | K(14,3) : | 13.8 |
D(3) : | 14.3 |
| RSI | RSI(14): 37.7 |
|||
| 52-week | High : | 110 | Low : | 67.45 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ CVS ] has closed above bottom band by 29.3%. Bollinger Bands are 56% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 95.36 - 95.74 | 95.74 - 96.06 |
| Low: | 92.84 - 93.31 | 93.31 - 93.71 |
| Close: | 94.1 - 94.87 | 94.87 - 95.52 |
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Tue, 18 Aug 2026
Why Is CVS Health (CVS) Adding A Data Leader To Its Board? - Yahoo Finance
Tue, 18 Aug 2026
CVS adds JPMorgan data executive to board amid AI push - Healthcare Dive
Tue, 18 Aug 2026
How Should You Approach CVS Health Stock After Q2 Earnings? - TradingView
Tue, 18 Aug 2026
Perigon Wealth Management LLC Makes New Investment in CVS Health Corporation $CVS - MarketBeat
Tue, 18 Aug 2026
Trust Co. of Vermont Acquires New Stake in CVS Health Corporation $CVS - MarketBeat
Tue, 18 Aug 2026
BlackRock Inc. Buys Shares of 123,223,409 CVS Health Corporation $CVS - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 1,280 (M) |
| Shares Float | 1,280 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 89.7 (%) |
| Shares Short | 19,520 (K) |
| Shares Short P.Month | 23,190 (K) |
| EPS | 3.78 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 62.36 |
| Profit Margin | 1.1 % |
| Operating Margin | 3.8 % |
| Return on Assets (ttm) | 2.9 % |
| Return on Equity (ttm) | 6.1 % |
| Qtrly Rev. Growth | 7 % |
| Gross Profit (p.s.) | 43.99 |
| Sales Per Share | 322.37 |
| EBITDA (p.s.) | 13.03 |
| Qtrly Earnings Growth | 188.8 % |
| Operating Cash Flow | 14,780 (M) |
| Levered Free Cash Flow | 8,080 (M) |
| PE Ratio | 25.04 |
| PEG Ratio | 0.2 |
| Price to Book value | 1.52 |
| Price to Sales | 0.29 |
| Price to Cash Flow | 8.21 |
| Dividend | 0.67 |
| Forward Dividend | 0 |
| Dividend Yield | 0.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|